Pontus Stenetorp is a Professor of Natural Language Processing at University College London (UCL) and holds a Specially Appointed Professorship at the National Institute of Informatics (NII) in Japan. At UCL, he leads the NLP Group, serves as Deputy Director of the Centre for Artificial Intelligence, and directs the Facebook Artificial Intelligence/UCL PhD Programme. His research focuses on the intersection of human language and computational systems, emphasizing empirical approaches to advancing and evaluating language processing capabilities. He is affiliated with UCL's Department of Computer Science and NII's Large Language Model Research and Development Center. Stenetorp prioritizes in-person collaboration for internships and research visits due to institutional bureaucratic constraints at UCL. He actively supervises MSc theses in Machine Learning and Data Science programs but restricts undergraduate and industry-oriented projects to exceptional cases. Communication preferences include structured emails sent to role-specific addresses: p.stenetorp@cs.ucl.ac.uk (UCL), pontus@nii.ac.jp (NII), and pontus@stenetorp.se (general). His research group, the NLP Group at UCL, pursues cutting-edge projects in computational linguistics and AI, often involving collaborative efforts with students and industry partners. While no specific awards are listed, his dual institutional roles underscore his significant contributions to the field of NLP and AI research.
Dr. Jennifer Dahne is a Professor of Psychiatry and Behavioral Sciences and the Melvyn Berlinsky Distinguished Endowed Chair in Cancer Research at the Medical University of South Carolina (MUSC). She holds leadership roles in MUSC’s Innovation Sciences Unit and the South Carolina Clinical & Translational Research Institute. Her research focuses on leveraging digital health technologies to address behavioral health disorders, particularly depression and substance use, with an emphasis on vulnerable populations. She also pioneers decentralized clinical trials and co-founded two digital health startups. Dr. Dahne’s work is supported by NIH grants (R01, R21, R41, R42, K23) and emphasizes translational research and commercialization of academic innovations. Education: Ph.D. in Clinical Psychology, University of Maryland, College Park (2016) Predoc Internship: MUSC/Ralph H. Johnson VA Medical Center Postdoc Fellowship: NIDA T32 Training Program (MUSC) Research Interests: Dr. Dahne’s work centers on digital health solutions to improve mental health care accessibility and efficacy. Key areas include: Decentralized clinical trials (remote/virtual trials) Telehealth and mobile health interventions for depression and substance use Health equity in digital health adoption Innovative clinical trial methodologies Awards & Leadership: Melvyn Berlinsky Distinguished Endowed Chair (2023) Inaugural Director, MUSC Innovation Sciences Unit (2022) Leadership roles in the SC Clinical & Translational Research Institute and Telehealth Center of Excellence Grants & Advising: Over 15 NIH grants awarded, including R01 and K-series. Her lab focuses on scalable interventions and has mentored students in digital health R&D. Collaborations span academia and industry through her startups and innovation initiatives. Labs & Teams: Research lab details available via MUSC’s Research Profile link. Active in cross-disciplinary teams advancing digital health and clinical trial innovation.
James Shorter is a Professor of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. He is affiliated with multiple prestigious institutes, including the Institute on Aging (IOA), the Institute for Translational Medicine and Therapeutics (ITMAT), the Penn Center for AIDS Research (CFAR), the Chemistry-Biology Interface (CBI), and the Penn Institute for RNA Innovation. He mentors several training programs such as the Penn Summer Undergraduate Internship Program (SUIP), PennPREP, and the Translational Research Immersion Program (TRIP), and serves as a Primary Trainer at the Center for Neurodegenerative Research (CNDR). Ph.D. in Cell Biology, University of London, 2000 M.A. in Biology, University of Oxford, 1995 Dr. Shorter’s research focuses on protein homeostasis, particularly the mechanisms of protein disaggregation and the role of prion-like domains in neurodegenerative diseases such as ALS, Alzheimer’s, Parkinson’s, and frontotemporal lobar degeneration. His lab investigates the Hsp104 disaggregase from yeast and has engineered variants to combat human proteinopathies. They also identified the mammalian disaggregase system (Hsp110/Hsp70/Hsp40) and explore how small molecules and nuclear import receptors can reverse pathological phase transitions of RNA-binding proteins like TDP-43 and FUS. His work bridges structural biology, genetics, and translational neuroscience. His recent publications highlight trends in targeting TDP-43 and FUS proteinopathies, engineering Hsp104 for selective detoxification, understanding mitochondrial disaggregases like Skd3, and modulating phase transitions with nuclear import receptors. His research spans from fundamental mechanisms of protein folding to therapeutic development for neurodegenerative diseases. Faculty Member, Institute on Aging (IOA) Faculty Member, Institute for Translational Medicine and Therapeutics (ITMAT) Mentor, Penn Summer Undergraduate Internship Program (SUIP) Primary Trainer, Center for Neurodegenerative Research (CNDR) Faculty Member, Penn Center for AIDS Research (CFAR) Member, Penn Institute for RNA Innovation Mentor, Translational Research Immersion Program (TRIP) Dr. Shorter advises numerous graduate students and postdoctoral researchers through the Biochemistry and Molecular Biophysics, Pharmacology, Neuroscience, and Cell and Molecular Biology graduate groups. His lab receives funding from NIH and other sources to support research on protein disaggregation, phase separation, and neurodegenerative disease mechanisms. He has trained many scientists now active in academia and biotech. His lab, located in Stellar-Chance Laboratories, operates at the intersection of biochemistry, cell biology, and translational medicine, with active projects on Hsp104 engineering, mitochondrial proteostasis, and the role of RNA-binding proteins in disease. The lab collaborates widely across Penn and with international partners to advance understanding and treatment of protein misfolding disorders.
Andrew Warfield is an Adjunct Professor in the Department of Computer Science at the University of British Columbia (UBC) and a Senior Principal Engineer at Amazon. His research focuses on computer systems software, including virtualization, distributed storage, security, and high-availability systems. He previously held roles as Associate Professor at UBC, CTO at Coho Data, and Technical Director at Citrix Systems. His work has led to projects like Remus (high-availability replication), Tralfamadore (execution analysis), and secure hypervisor development with Xen. Warfield's education includes a PhD from the University of Cambridge's Computer Laboratory, where he researched I/O device virtualization under Steven Hand. He has held visiting roles at Intel Research Cambridge and internships at AT&T Research and Nortel Networks. Research Grants: Supported by Intel Research, NSERC, Network Appliance, and the Communications Security Establishment. Professional Activities: Technical Advisory Board Member at Teradici, and involvement in program committees for conferences like HotOS, EuroSys, and FAST. His research emphasizes practical systems, aiming to bridge the gap between theoretical computer science and real-world applications. Notable contributions include innovations in storage for virtualized environments, secure hypervisor architectures, and disaster-tolerant systems like SecondSite. Warfield is affiliated with UBC's Department of Computer Science and maintains active collaboration with industry partners. Though currently not actively recruiting students, his prior mentorship has influenced many in systems research.
Wendy Balliet is an Assistant Professor at the Medical University of South Carolina (MUSC), affiliated with the College of Medicine and the Department of Psychiatry and Behavioral Sciences. She earned her PhD in counseling psychology with a health psychology concentration from Virginia Commonwealth University, completed a pre-doctoral internship at the University of Florida Health Science Center (Medical Psychology rotation), and a postdoctoral fellowship in behavioral medicine at MUSC. Key Roles: Associate Co-Director of Clinical Operations for the Division of Bio-behavioral Medicine Supervisor for interns in the Behavioral Medicine Clinic (Charleston Consortium Psychology Internship Program) Researcher and clinical provider in psycho-oncology and transplant behavioral health Her research focuses on behavioral medicine , psycho-oncology , and transplant/living donation psychology. She investigates body image distress in cancer survivors , mental health in transplant populations , and telemedicine-based cognitive behavioral therapy (CBT) . Her work includes the BRIGHT trial for tele-CBT in head and neck cancer survivors and studies on caregiver burden, peer mentoring programs (TRIO), and psychosocial factors in organ transplantation. Her clinical efforts span patient care, committee service (Grand Rounds, hospital-wide initiatives), and training for postdoctoral fellows and medical students. She emphasizes integrating psychosocial interventions with medical outcomes , particularly in cancer and transplant settings, and has developed educational resources like the Organ Transplant Caregiver Toolkit.
Dr. James Kempton is an Associate Professor of Ophthalmology & Visual Science at Yale School of Medicine , where he has served since 2009. He also directs Eye Care Services at the West Haven Veterans Administration and co-leads Yale's Vitreoretinal Fellowship Program and Ophthalmology Residency Program. Double Board-Certified in Internal Medicine & Ophthalmology Specializes in Retinal Surgery and Trauma-Associated Vitreoretinal Diseases Research Focus: Clinical management of Diabetic Retinopathy , Macular Degeneration , and Retinal Detachment , combined with innovative Systems Approaches in Medical Education . Education MD, Ohio State University (1997) Internship: Combined Internal Medicine/Pediatrics at Medical College of Virginia Residency: Yale Internal Medicine Primary Care Chief Residency: Hospital of Saint Raphael Ophthalmology Residency & Fellowship: Yale University Honors Recipient of the prestigious Marvin L. Sears Award for Clinical Excellence Clinical Expertise includes laser treatments and surgical interventions for retinal disorders, with a focus on Diabetic Retinopathy , Macular Degeneration , and Retinal Trauma . He serves as Associate Program Director for both Yale's Ophthalmology Residency and Vitreoretinal Fellowship programs.
Dr. Prerna Arora is Associate Professor of Psychology and Education at Teachers College, Columbia University, within the Graduate School of Education, Health & Psychology and the Department of Health Studies & Applied Educational Psychology. She directs the School Mental Health for Minoritized Youth and Families (SMILE) Research Lab, where she leads innovative research on mental health equity for immigrant-origin, racial and ethnic minoritized, and historically marginalized youth. Ph.D. in School Psychology – University of Texas at Austin M.A. in Educational Psychology – University of Texas at Austin B.S. in Biology – Arizona State University Predoctoral Internship – Children’s Hospital of Philadelphia Postdoctoral Training – University of Maryland School of Medicine Dr. Arora’s research focuses on culturally tailored mental health interventions, school-based services, barriers to care, and trauma-informed, equity-driven practices. Her work is grounded in participatory action research and mixed methods, aiming to bridge research-practice gaps and empower communities. She has led major funded projects from the Spencer Foundation, National Institute of Mental Health (NIMH), and the U.S. Department of Education, including a $4.9 million grant to train clinicians in culturally responsive services. Her recent publications reflect a strong thematic focus on mental health disparities, cultural adaptation of interventions, school climate, and help-seeking behaviors among AAPI, Latino/a, and immigrant youth. The body of work demonstrates a commitment to advancing equity, social justice, and measurement-based care in school psychology. American Psychological Association Minority Fellowship Program Spencer Foundation Research Grant NIMH Funding U.S. Department of Education OSEP Grant ($4.9 million) Dr. Arora actively mentors PhD and graduate students, many of whom co-author her publications. She has secured major grants that support training, research, and community partnerships. Her leadership extends to editorial roles as Associate Editor of School Mental Health and Consulting Editor of School Psychology Review , and she is a vocal advocate for diversity, equity, and inclusion in academic training and practice. She collaborates extensively with NYC-based organizations, building community-driven research models through the SMILE Lab.
Sherry Tongshuang Wu is an Assistant Professor at Carnegie Mellon University's School of Computer Science, with primary appointments in the Human-Computer Interaction Institute (HCII) and secondary affiliation with the Language Technology Institute (LTI) . Trained at the University of Washington under Jeffrey Heer and Dan Weld, she bridges HCI and NLP to study human interactions with AI systems across diverse user groups. Her educational background includes a Ph.D. (2016-22) and M.S. (2016-18) in Computer Science and Engineering from the University of Washington, and a B.Eng. (2012-16) from Hong Kong University of Science and Technology. Industry experience includes research internships at Google Brain, Microsoft Research, and Apple. Wu's research focuses on three interconnected pillars: Real-world AI Evaluation (developing frameworks like SPHERE for systematic assessment), Task-specific AI Test & Distill (optimizing general-purpose models for specific use cases), and Human-AI Task Delegation (designing optimal collaboration between humans and AI). Her work emphasizes practical deployment, user-specific net gains, and error recovery mechanisms. Analysis of her 15 most recent publications reveals a strong trend toward evaluation frameworks (35%), human-AI collaboration systems (30%), and specialized model distillation (25%), with growing emphasis on educational applications (10%). Key methodological themes include checklist-based evaluation, perspective-aware retrieval, and structural analysis of AI outputs. Google Academic Research Award (2024) Amazon Research Awards (2024) AIED 2024 Best Paper Award ACL 2020 Best Paper Award Rising Stars in EECS Workshop (2020) Wu actively mentors 19 students across PhD, Master's, and undergraduate levels, with notable projects including synthetic data generation, LLM literacy tools, and retrieval system optimization. She leads significant grant-funded work through Amazon Research Awards and Google Academic Research Awards, focusing on deployable model generation and human-AI collaboration frameworks. Her lab develops practical tools like Promp2Model and SPHERE that bridge theoretical research with industry applications.
Ying-Yi Chih is a Professor of Project Management at the Research School of Management, Australian National University (ANU) , and serves as the Associate Dean (Students and Industry Experience) for the College of Business and Economics. Her research focuses on project management, public-private partnerships (PPPs), value co-creation in projects, and employee well-being in project-based environments like the construction industry. She has published extensively in journals such as International Journal of Project Management and Journal of Construction Engineering and Management , with funding from government and industry sources. Education: PhD in Project Management Research Interests include: Infrastructure Project Planning and Management Public-Private Partnerships (PPPs) Value Co-Creation in Professional Services Employee Psychological Well-being and Performance Management Recent Publications highlight trends in green innovation, crisis resilience, leadership dynamics, and technology adoption in construction and project management. Her work bridges theoretical frameworks with practical applications in the AEC (Architecture, Engineering, Construction) industry and public sector projects. Editorial Roles: Associate Editor for Journal of Management in Engineering and Editorial Board member for Journal of Vocational Behavior . Research Projects have explored value co-creation, international development projects, and performance management in multi-project environments, with collaborations across Australia, Taiwan, Vietnam, and the Philippines.
Angela Birnbaum is a Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy. She serves as Associate Director of the Center for Clinical and Cognitive Neuropharmacology and is a Fellow of The American Epilepsy Society (FAES). Her research focuses on translational clinical pharmacology with emphasis on special populations including the elderly, pregnant women, children, and those with drug addiction. Dr. Birnbaum earned her PhD in Pharmacology (with a Neuroscience minor) from the University of Minnesota Department of Pharmacology. She completed her undergraduate studies with a Bachelor of Science and Medical Technology (BSMT) with chemistry minor from Ohio Northern University, along with a Bachelor of Biology (BS). She also completed a Medical Technology Internship at St. Rita's Medical Center and a Post-doctoral Fellowship in Clinical Neuropharmacology at the University of Minnesota. Her research program centers on pharmacokinetics and pharmacodynamics in special populations, with particular expertise in antiepileptic drugs. She investigates drug concentration variability and response across different patient groups, with significant work on medications like lamotrigine, carbamazepine, and lacosamide. Her laboratory operates as a Pharmacokinetics Laboratory Core for various grant projects and explores drug stability both in vivo and in vitro. Dr. Birnbaum's recent publications demonstrate a strong focus on pregnancy-related pharmacokinetics, particularly for antiepileptic medications, and pharmacokinetic considerations for vulnerable populations including neonates and critically ill patients. Her work combines pharmacometric modeling with clinical research to optimize drug dosing across diverse patient populations. Among her notable recognitions: Fellow of The American Epilepsy Society (FAES) Designation as Center of Excellence for Model-based Drug Development (MBDD) Certara Center of Excellence designation for her program Dr. Birnbaum has been principal investigator and collaborator on numerous research projects funded by the National Institutes of Health, pharmaceutical industry, instrumentation companies, and foundations. Her current projects include investigations into antiseizure medication exposure during pregnancy and breastfeeding, development of monoclonal antibodies to reverse fentanyl overdose, and clinical trials of multivalent opioid vaccine components. Her laboratory, the Birnbaum Laboratory for Translational Clinical Neuropharmacology, operates as both an independent research program investigating drug effects on cognition and a Pharmacokinetics Laboratory Core supporting multiple research projects. The lab incorporates Certara's Phoenix software suite into thesis and research projects, reflecting their expertise in model-based drug development.
Allison Godwin is a Professor in the Department of Chemical Engineering at Cornell University, joining the faculty in 2023. She holds a B.S. (2011) and Ph.D. (2014) in Chemical Engineering and Science Education from Clemson University. At Purdue University, she was a tenured member of the School of Engineering Education and held a joint appointment in the Davidson School of Chemical Engineering (2020). Research Interests: Engineering identity development, particularly for underrepresented groups Inclusive pedagogies to reduce equity gaps in STEM Engineering workforce diversity and retention strategies Mixed-methods research on belonging and motivation Scientific Awards: 2023 American Institute of Chemical Engineers Award for Excellence in Engineering Education Research 2022 AERA Division I Outstanding Research Publication Award 2021 CEE William H. Corcoran Award 2017-Present NSF CAREER Award 2016 NARST Outstanding Doctoral Dissertation Award Leadership Roles: Past Chair of ASEE Educational Research Methods Division (2021-2023) Associate Editor for Chemical Engineering Education (2020-Present) Co-led Purdue’s Faculty Learning Community for inclusive teaching
Przemysław Kordos is a Professor at the University of Warsaw , affiliated with the Faculty of Liberal Arts , where he serves as Coordinator for the Development of the Modern Greek Philology Program . He holds two PhDs in Humanities (2007, 2019) and was awarded the Loukis Papaphilippou Seat of Advancement in Modern Greek scholarship. Education: MA in Ethnology and Cultural Anthropology (University of Warsaw, 2001) MS in Sociology (University of Warsaw, 2002) PhD in Humanities (University of Warsaw, 2007) Second PhD in Humanities (University of Warsaw, 2019) His research interests span: Contemporary Modern Greek and Cypriot literature Polish-Greek cultural relations (philhellenism) Social and ethnographic issues in Greece and Cyprus Travel literature analysis Fantasy literature's cultural implications His scientific work reveals a focus on linguistic assimilation in foreign language learning (via fMRI studies), historical parallels between Polish and Greek independence movements, and critical analyses of Cypriot folk culture's politicization. Key scientific awards include: Loukis Papaphilippou Seat (University of Warsaw) Internships at EKPA and IKY (Greece) Scholarships at IMXA (Greece) and MUNI (Czech Republic) His academic contributions include cataloging 60+ Polish travel accounts to Greece, analyzing the shift from travel literature to tourism discourse, and examining the Hellene-Romios dichotomy's role in modern Greek identity construction.
Matthew B Potts, MD is an Associate Professor in the Department of Neurological Surgery at Northwestern University's Feinberg School of Medicine, with secondary appointments in Neurology (Ken and Ruth Davee Department) and Radiology. His clinical expertise spans cerebrovascular surgery, neurointerventional/endovascular procedures, and management of brain aneurysms, vascular malformations, stroke, and spinal vascular disease across multiple Northwestern Medicine hospitals including Shirley Ryan AbilityLab. Dr. Potts completed his BS at MIT (2000) and MD at UCSF (2007), followed by surgical internship (2008), neurological surgery residency (2013), and cerebrovascular fellowship at NYU (2015). BS: Massachusetts Institute of Technology (2000) MD: University of California, San Francisco (2007) Internship: University of California-San Francisco Medical Center, Surgery (2008) Residency: University of California-San Francisco Medical Center, Neurological Surgery (2013) Fellowship: New York University Medical Center, Endovascular/Cerebrovascular Surgery (2015) His research program centers on chronic subdural hematoma pathophysiology, emergency stroke thrombectomy process optimization, and aneurysm treatment outcomes. He employs clinical-translational approaches to improve cerebrovascular disease management through advanced surgical techniques and rigorous outcomes assessment. Recent 2025 publications reveal strong focus on hydrocephalus diagnostics, hematoma expansion biomarkers, vertebrobasilar anatomy, and dolichoectatic aneurysm natural history. These works demonstrate multidisciplinary collaboration across neurosurgery, neurology, and radiology to advance diagnostic precision and treatment efficacy in complex cerebrovascular disorders. Dr. Potts has received exceptional recognition for medical education, including three consecutive Outstanding Teacher Awards (2019-2021) and the John X. Thomas, Jr. Best Teachers Award (2020). His research contributions are honored by the NIH Rush L. Kirschstein Award (2012) and Howard Hughes Fellowship (2005). Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2021) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) John X. Thomas, Jr. Best Teachers of Feinberg Award, Northwestern University Feinberg School of Medicine (2020) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2019) Ivan Ciric Resident Teaching Award, Northwestern University Department of Neurological Surgery (2017) Best Scientific Presentation, UCSF Department of Neurological Surgery (2013) NIH Rush L. Kirschstein National Research Service Award, National Institutes of Health (2012) UCSF School of Medicine Alumni Scholarship Award, University of California, San Francisco (2006) Howard Hughes Medical Institute Medical Student Research Fellow, Howard Hughes Medical Institute (2005) UCSF Quarterly Research Fellowship, University of California, San Francisco (2005) MIT-Germany Program Research Fellowship, Massachusetts Institute of Technology (2001) As an educator, Dr. Potts mentors medical students and residents through Feinberg's neurological surgery program, evidenced by his resident teaching award. His research is supported by institutional resources and prior NIH funding, with current industry relationships including ownership in Rhaeos, Inc. He serves as Assistant Editor for Neurosurgery and Associate Editor for Operative Neurosurgery. He operates within Northwestern's integrated neurovascular team across multiple hospital sites, collaborating with neurologists, neuroradiologists, and rehabilitation specialists to deliver comprehensive care for complex cerebrovascular conditions, with ongoing work focused on improving health equity in stroke treatment and minimally invasive surgical innovation.
Lauren M. Lipner, Ph.D., is an Assistant Professor in the Clinical Psychology Doctoral Program at Long Island University (LIU) Post, within the College of Liberal Arts and Sciences. She holds a B.A. from Pennsylvania State University and earned her M.A. and Ph.D. in Clinical Psychology from Adelphi University in 2020. Her academic and clinical training includes an APA-accredited pre-doctoral internship at Pennsylvania Hospital/University of Pennsylvania Health System, a clinical postdoctoral fellowship at Mount Sinai Beth Israel, and a research and teaching postdoctoral fellowship at Adelphi University. Her research focuses on psychotherapy process and outcome, with an emphasis on the development and repair of the therapeutic alliance. Key areas include alliance rupture resolution, factors contributing to premature treatment termination, and methodological approaches to measuring therapeutic dynamics. She has contributed extensively to the literature through peer-reviewed journal articles, book chapters, and conference presentations. The most recent publications reflect a strong trend in advancing methodological rigor in studying alliance ruptures, utilizing control chart methods, single-case designs, and multi-method approaches. Her work bridges clinical practice with empirical research, particularly in cognitive-behavioral and integrative therapies for personality and anxiety disorders. Scientific awards and grants highlight her recognition in the field: Small Research Grant, Society for Psychotherapy Research (2021) Charles J. Gelso, Ph.D. Psychotherapy Research Grant, Society for the Advancement of Psychotherapy (APA Division 29, 2023) Dr. Lipner has served as Principal Investigator on funded projects including 'The relationship between therapist flexibility, alliance rupture resolution, and premature treatment termination' and 'Reasons for dropout measure: Development and validation.' She is actively involved in professional organizations such as the American Psychological Association (Divisions 12 and 29), the Society for Psychotherapy Research, and the Society for the Exploration of Psychotherapy Integration. She regularly presents her research at national and international conferences, contributing to training and supervision literature, particularly in CBT and alliance-focused models. While no specific lab or research team is explicitly named in the text, her collaborative work with prominent researchers like Jeremy D. Safran, J. Christopher Muran, and Jacqueline P. Barber suggests active participation in a research network focused on psychotherapy process and integration. Her contributions to handbooks and case studies further indicate a strong commitment to clinical education and training.
Katherine R. Baker, M.D., is a Clinical Associate Professor of Pediatrics at the University of Rochester School of Medicine and Dentistry and part of the University of Rochester Medical Faculty Group (URMFG). She serves as the Director of Practice Innovation for Patient, Family, and Community Engagement at Golisano Children's Hospital Pediatric Practice. Her clinical focus includes newborn care, lactation support, and trauma-informed care. Education: MD from Drexel University College of Medicine (2008) Residency in Pediatrics at University of Wisconsin Hospital and Clinics (2009–2011) Internship in Pediatrics at University of Wisconsin Hospital and Clinics (2008–2009) Dr. Baker’s research emphasizes medical education, physician wellness, and the medical home model. She aims to enhance resident training in well-child and acute care settings, prepare trainees for global health work, and integrate mental health and breastfeeding support into medical home frameworks. Her work also focuses on mitigating burnout and promoting physician wellness. Scientific Awards: American Academy of Pediatrics Clinical Case Presentation Winner (2009) Alpha Omega Alpha Medical Honor Society (2007) Award for Excellence in Program for Integrated Learning (2006) Mary C. Riforgiato Scholarship Recipient (2001–2002) Phi Eta Sigma National Honor Society (1998–2002) New York State Society for Clinical Laboratory Science Student of the Year (1998–2002)
